Substantial activity of thalidomide in multiple myeloma, study shows

被引：0
|
作者：
不详
机构：
来源：
ONCOLOGY-NEW YORK | 2000年 / 14卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：452 / 452
页数：1
相关论文
共 50 条
  • [41] Thalidomide for the treatment of leptomeningeal multiple myeloma
    Hattori, Y
    Yabe, M
    Okamoto, S
    Morita, K
    Tanigawara, Y
    Ikeda, Y
    EUROPEAN JOURNAL OF HAEMATOLOGY, 2006, 76 (04) : 358 - 359
  • [42] Thalidomide in refractory and relapsing multiple myeloma
    Bladé, J
    Esteve, J
    Rosiñol, L
    Perales, M
    Montoto, S
    Tuset, M
    Montserrat, E
    SEMINARS IN ONCOLOGY, 2001, 28 (06) : 588 - 592
  • [43] Thalidomide in the treatment of relapsed multiple myeloma
    Rajkumar, SV
    Fonseca, R
    Dispenzieri, A
    Lacy, MQ
    Lust, JA
    Witzig, TE
    Kyle, RA
    Gertz, MA
    Greipp, PR
    MAYO CLINIC PROCEEDINGS, 2000, 75 (09) : 897 - 901
  • [44] Thalidomide and dexamethasone: therapy for multiple myeloma
    Kumar, Shoji
    Rajkumar, S. Vincent
    EXPERT REVIEW OF ANTICANCER THERAPY, 2005, 5 (05) : 759 - 766
  • [45] Thalidomide in multiple myeloma: state of art
    Tosi, P
    Cavo, M
    HAEMATOLOGICA, 2002, 87 (03) : 233 - 234
  • [46] Thalidomide and lenalidomide in the treatment of multiple myeloma
    Kumar, Shaji
    Rajkumar, S. Vincent
    EUROPEAN JOURNAL OF CANCER, 2006, 42 (11) : 1612 - 1622
  • [47] Erucylphospho-N,N,N-trimethylpropylammonium Shows Substantial Cytotoxicity in Multiple Myeloma Cells
    Yosifov, Deyan Y.
    Konstantinov, Spiro M.
    Berger, Martin R.
    NATURAL COMPOUNDS AND THEIR ROLE IN APOPTOTIC CELL SIGNALING PATHWAYS, 2009, 1171 : 350 - 358
  • [48] In vitro study of the hypercoagulable state in multiple myeloma patients treated or not with thalidomide
    Petropoulou, Anna D.
    Gerotziafas, Grigoris T.
    Samama, Meyer M.
    Hatmi, Mohamed
    Rendu, Francine
    Elalamy, Ismail
    THROMBOSIS RESEARCH, 2008, 121 (04) : 493 - 497
  • [49] Single dose pharmacokinetic study of thalidomide in patients with multiple myeloma.
    Pathak, A.
    Malhotra, J.
    Raina, V
    Arya, D. S.
    Gupta, Y. K.
    ACTA PHARMACOLOGICA SINICA, 2006, 27 : 218 - 218
  • [50] Phase II study of thalidomide with dexamethasone for relapsed/refractory multiple myeloma
    Kinoshita, T
    Ohno, T
    Yuge, M
    Hiraga, J
    Matsushita, T
    Ando, S
    Naoe, T
    ANNALS OF ONCOLOGY, 2005, 16 : 206 - 206
12345